2003 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Keith M. Sullivan mainly investigates Transplantation, Surgery, Internal medicine, Gastroenterology and Bone marrow. The study incorporates disciplines such as Aplastic anemia, Sickle cell anemia, Disease and Immunology in addition to Transplantation. His Surgery study frequently draws connections to other fields, such as Anemia.
His is doing research in Leukemia, Hematopoietic stem cell transplantation, Graft-versus-host disease, Immunosuppression and Cumulative incidence, both of which are found in Internal medicine. The various areas that Keith M. Sullivan examines in his Gastroenterology study include Preparative Regimen, Adverse effect, Azathioprine and Acute lymphocytic leukemia. His research integrates issues of Lymphoproliferative disorders, Lymphoma, Incidence, Urology and Pulmonary function testing in his study of Bone marrow.
Internal medicine, Transplantation, Surgery, Gastroenterology and Immunology are his primary areas of study. His Internal medicine study frequently draws connections between adjacent fields such as Oncology. Keith M. Sullivan combines subjects such as Aplastic anemia, Bone marrow and Total body irradiation with his study of Transplantation.
His Surgery research is multidisciplinary, relying on both Immunosuppression and Incidence. His study in Gastroenterology is interdisciplinary in nature, drawing from both Methotrexate, Randomized controlled trial, Cumulative incidence, Methylprednisolone and Fludarabine. His studies deal with areas such as Scleroderma and Toxicity as well as Cyclophosphamide.
Keith M. Sullivan focuses on Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Surgery. Keith M. Sullivan interconnects Gastroenterology and Placebo in the investigation of issues within Internal medicine. Keith M. Sullivan studies Graft-versus-host disease, a branch of Transplantation.
His research in Hematopoietic stem cell transplantation intersects with topics in Incidence, Retrospective cohort study, Immunology, Clinical endpoint and Salvage therapy. His Oncology study incorporates themes from Hematopoietic Stem Cell Mobilization, Granulocyte colony-stimulating factor, Quality of life, Marrow transplantation and Hematopoietic stem cell. His Cyclophosphamide research incorporates elements of Immunosuppression, Randomized controlled trial and Scleroderma.
The scientist’s investigation covers issues in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Autologous stem-cell transplantation. His Internal medicine research is multidisciplinary, incorporating elements of Placebo, Surgery and Oncology. His research in Surgery tackles topics such as Gastroenterology which are related to areas like Pathology.
His studies in Transplantation integrate themes in fields like Umbilical cord, Transplantation Conditioning, Haematopoiesis and Herpes Zoster Vaccine. His work on Histocompatibility Testing as part of general Immunology study is frequently linked to Surgical mask, therefore connecting diverse disciplines of science. The Autologous stem-cell transplantation study combines topics in areas such as Adverse effect and Cyclophosphamide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 seattle patients
Howard M. Shulman;Keith M. Sullivan;Paul L. Weiden;George B. McDonald.
The American Journal of Medicine (1980)
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
Rainer Storb;H. Joachim Deeg;John Whitehead;Frederick Appelbaum.
The New England Journal of Medicine (1986)
MASON: A Multiagent Simulation Environment
Sean Luke;Claudio Cioffi-Revilla;Liviu Panait;Keith Sullivan.
international conference on advances in system simulation (2005)
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.
Paul L. Weiden;Keith M. Sullivan;Nancy Flournoy;Rainer Storb.
The New England Journal of Medicine (1981)
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression
KM Sullivan;HM Shulman;R Storb;PL Weiden.
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
K M Sullivan;P L Weiden;R Storb;R P Witherspoon.
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
K M Sullivan;E Agura;C Anasetti;F Appelbaum.
Seminars in Hematology (1991)
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
JE Sanders;J Hawley;W Levy;T Gooley.
Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
John A. Hansen;Theodore A. Gooley;Paul J. Martin;Frederick Appelbaum.
The New England Journal of Medicine (1998)
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: